-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AOlOHK2MUn1Q4KuOiCVeEyuSsFa/KqBMPR0rN02aRlXzNGuXWjiTloSyXWTqHwGS i6n8QzGEpUfQnksIjqPKzw== 0000950135-03-004427.txt : 20030814 0000950135-03-004427.hdr.sgml : 20030814 20030814153140 ACCESSION NUMBER: 0000950135-03-004427 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030814 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20030814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FISHER SCIENTIFIC INTERNATIONAL INC CENTRAL INDEX KEY: 0000880430 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-PROFESSIONAL & COMMERCIAL EQUIPMENT & SUPPLIES [5040] IRS NUMBER: 020451017 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10920 FILM NUMBER: 03847221 BUSINESS ADDRESS: STREET 1: LIBERTY LANE CITY: HAMPTON STATE: NH ZIP: 03842 BUSINESS PHONE: 6039265911 MAIL ADDRESS: STREET 1: LIBERTY LANE CITY: LIBEHAMPTON STATE: NH ZIP: 03842 8-K 1 b47475fse8vk.txt FISHER SCIENTIFIC INTERNATIONAL, INC. - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 --------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2003 ------------------- FISHER SCIENTIFIC INTERNATIONAL INC. (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation) 1-10920 02-0451017 (Commission File No.) (IRS Employer Identification No.) ONE LIBERTY LANE, HAMPTON, NEW HAMPSHIRE 03842 (Address of principal executive offices) (Zip Code) (603) 926-5911 (Registrant's telephone number, including area code) - -------------------------------------------------------------------------------- ITEM 9. REGULATION FD DISCLOSURE. Attached hereto as Exhibit 99.1 is the registrant's press release dated August 14, 2003 announcing the extension of the acceptance period for the cash offer in Sweden to purchase all the outstanding shares and certain warrants of Perbio Science AB to August 25, 2003. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FISHER SCIENTIFIC INTERNATIONAL INC. DATE August 14, 2003 BY: /s/ Todd M. Duchene -------------------------------------- NAME: Todd M. DuChene TITLE: Vice President - General Counsel and Secretary EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION - -------------- ----------- Exhibit 99.1 Fisher Scientific International Inc.'s press release dated August 14, 2003 announcing the extension of the acceptance period for the cash offer in Sweden to purchase all the outstanding shares and certain warrants of Perbio Science AB to August 25, 2003. EX-99.1 3 b47475fsexv99w1.txt PRESS RELEASE DATED 08/14/2003 [LOGO] FISHER SCIENTIFIC INTERNATIONAL INC. NEWS RELEASE Media Contact: Investor Contact: Gia L. Oei, 603-929-2489 Carolyn Miller, 603-929-2381 E-mail: Gia.Oei@nh.fishersci.com E-mail: Carolyn.Miller@nh.fishersci.com FISHER SCIENTIFIC EXTENDS ACCEPTANCE PERIOD FOR OFFER TO PERBIO SCIENCE AB SHAREHOLDERS HAMPTON, N.H., Aug. 14, 2003 -- Fisher Scientific International Inc. (NYSE: FSH) announced today that it has extended the acceptance period for its cash offer (the "Offer") to purchase all of the outstanding shares and certain warrants of Perbio Science AB (Stockholm: PBIO) until 4 p.m. Central European Time (CET) on Aug. 25. The board of directors of Perbio has unanimously recommended the acceptance of the Offer, and all terms and conditions of the Offer remain the same. The board of directors and management of Perbio have undertaken to tender their shares and warrants under the Offer. Based upon future events and circumstances occurring during and at the end of the Offer, including the number of shares tendered, Fisher may consider waiving the 90 percent minimum acceptance condition. Perbio Science is a $250 million manufacturer and supplier of technologies, products and services to the life-science and biotechnology industries. ABOUT FISHER SCIENTIFIC INTERNATIONAL INC. Fisher Scientific International Inc. (NYSE: FSH) is the world leader in serving science. We enable scientific discovery and clinical-laboratory testing services by offering more than 600,000 products and services to over 350,000 customers in approximately 145 countries. As a result of our broad product offering, electronic-commerce capabilities, and integrated global logistics network, Fisher serves as a one-stop source of products, services and global solutions for many of our customers. The company primarily serves the scientific-research, clinical-laboratory and safety markets. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com. - more - Fisher Scientific Extends Acceptance Period for Offer to Perbio Shareholders - 2 UNITED STATES The offer is not being made, and this announcement does not constitute an offer, directly or indirectly, in or into the United States of America or to any resident of the United States of America, and the offer may not be accepted in or from the United States of America. This announcement includes forward-looking statements. Fisher Scientific has based these forward-looking statements on its current expectations and projections about future events. Although Fisher Scientific believes that its assumptions made in connection with the forward-looking statements are reasonable, no assurances can be given that its assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions. Fisher Scientific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur. # -----END PRIVACY-ENHANCED MESSAGE-----